Published in Health Risk Factor Week, April 24th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Eisai.
Report 1: Eisai Research Institute of Boston, Inc., a pharmaceutical research and development subsidiary of Tokyo-based Eisai Co., Ltd., announces the opening of a new facility at its site in Andover, Massachusetts.
The 150,000 square foot structure will consolidate basic discovery research operations and provide for future growth.
The $65 million facility will be devoted to discovery research utilizing a combination of natural products-based synthetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.